Dr Machaalani on overcoming acquired resistance through AXL and c-MET inhibition in RCC
Published in OncLive, 2024
Discussion on targeting AXL and c-MET pathways to overcome acquired resistance in renal cell carcinoma.
Marc Machaalani, MD
Postdoctoral Research Fellow
- Boston, MA
- Dana-Farber Cancer Institute
- Google Scholar
- ORCID
- PubMed
- ResearchGate
- X (formerly Twitter)